Form 13-F position report

MAPLIGHT THERAPEUTICS INC

Reported by STATE STREET CORPORATION

MPLT CUSIP 56565P103 Manager CIK 0000093751

Reported 852,150 shares, up 513,034 (151.3%) from the prior quarter.

Reported value 343.0%; share count 151.3% vs. the prior quarter.

Added
% of reported 13F value < 0.01% This manager · Q2 2026
Shares 852,150 Quarter-end amount reported
Reported value $30,541,056 Fair value at quarter end
Consecutive quarters held 3 Through Q2 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-12-31 4030886
2026-03-31 6894228
2026-06-30 30541056
2026-09-30 3195441

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for MAPLIGHT THERAPEUTICS INC held by STATE STREET CORPORATION.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 313,586 -538,564 (-63.2%) < 0.01% $3,195,441 2026-11-12
Q2 2026 Added 852,150 +513,034 (151.3%) < 0.01% $30,541,056 2026-08-07
Q1 2026 Added 339,116 +109,632 (47.8%) < 0.01% $6,894,228 2026-05-15
Q4 2025 New 229,484 +229,484 (0.0%) < 0.01% $4,030,886 2026-02-13

Who else reported the position

115 managers reported MAPLIGHT THERAPEUTICS INC for Q2 2026.

Managers reporting MAPLIGHT THERAPEUTICS INC in Q2 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Novo Holdings A S Unchanged 3,686,622 0 7.67% $132,128,532 3 qtrs
FCPM III SERVICES B V Unchanged 3,226,400 0 15.41% $115,634,176 3 qtrs
T Rowe Price Investment Management Inc Reduced 2,781,728 -20,209 0.07% $99,698,000 3 qtrs
The Goldman Sachs Group Inc Reduced 1,948,312 -46,561 < 0.01% $69,827,502 3 qtrs
PRICE T ROWE ASSOCIATES INC MD Added 1,422,935 +1,310,227 < 0.01% $50,999,000 2 qtrs
BlackRock Inc Reduced 1,025,134 -314,597 < 0.01% $36,740,802 3 qtrs
Nan Fung Group Holdings Ltd Unchanged 971,253 0 26.47% $34,809,708 3 qtrs
5AM Venture Management LLC Unchanged 950,011 0 11.83% $34,048,394 3 qtrs
Sanofi Unchanged 912,041 0 6.12% $32,687,549 3 qtrs
STATE STREET CORPORATION This report Added 852,150 +513,034 < 0.01% $30,541,056 3 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2026
Filed
August 07, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
91,702
Shared
0
None
760,448

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.